Key Highlights
•
The global supply of oral cholera vaccine is now adequate, allowing preventive vaccination campaigns to restart for the first time in over three years. This is a major public health milestone that will help protect vulnerable populations from deadly cholera outbreaks.
Source →
•
A new review examines the best drug treatments for fatty liver disease (MASLD) in people who also have type 2 diabetes. Finding the right medication is crucial because diabetes makes fatty liver disease worse and increases the risk of serious liver damage.
Source →
•
A study has created a practical roadmap for implementing Endoscopic Sleeve Gastroplasty (ESG), a minimally invasive weight-loss procedure, within the UK’s National Health Service. This framework is vital for standardizing care and making this effective obesity treatment more widely available to patients.
Source →
•
A large European study found that nearly half of patients with a specific type of lung disease linked to autoimmune vasculitis died within about 4 years. This highlights the severe nature of this condition and underscores the urgent need for early diagnosis and better treatments.
Source →
•
A major study of over 2,200 patients with cardiac amyloidosis shows the disease can cause heart failure across the full range of heart pumping strength, not just in hearts with preserved function. Combining different heart measurements provides a much better way to predict a patient’s outcome than using a single test alone.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
